• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Microvascular Capillary and Precapillary Cardiovascular Disturbances Strongly Interact to Severely Affect Tissue Perfusion and Mitochondrial Function

SWAlexander

Senior Member
Messages
1,945
Pre print Approved: 12 December 2023

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a frequent, debilitating and still enigmatic disease. There is a broad overlap in the symptomatology of ME/CFS and the Post-COVID Syndrome (PCS). A fraction of the PCS patients develops the full clinical picture of ME/CFS. New observations in microvessels and blood from patients suffering from PCS have appeared and include microclots and malformed pathological blood cells. Capillary blood flow is impaired not only by pathological blood components but also by prothrombotic changes in the vascular wall, endothelial dysfunction, and expression of adhesion molecules in the capillaries. These disturbances can finally cause a low capillary flow and even capillary stasis. A low cardiac stroke volume due to hypovolemia and the inability of the capacitance vessels to adequately constrict to deliver the necessary cardiac preload generate an unfavorable low precapillary perfusion pressure. Furthermore, a predominance of vasoconstrictor over vasodilator influences exists, in which sympathetic hyperactivity and endothelial dysfunction play a strong role, causing constriction of resistance vessels and of precapillary sphincters which leads to a fall in capillary pressure behind the sphincters. The interaction of these two precapillary cardiovascular mechanisms causing a low capillary perfusion pressure is hemodynamically highly unfavorable in the presence of a primary capillary stasis already caused by the pathological blood components and their interaction with the capillary wall, to severely impair organ perfusion. The detrimental coincidence of the microcirculatory with the precapillary cardiovascular disturbances may constitute the key disturbance of the Post-COVID-19 syndrome and finally lead to ME/CFS in pre-disposed patients because the interaction causes a particular kind of perfusion disturbance - capillary ischemia-reperfusion - which has a high potential of causing mitochondrial dysfunction by inducing sodium- and calcium-overload in skeletal muscles. The latter in turns worsens the vascular situation by the generation of reactive oxygen species to close a vicious cycle from which the patient can hardly escape.
https://www.preprints.org/manuscript/202312.0791/v1?s=03
 

Oliver3

Senior Member
Messages
863
This pisses me off as I've described these exact symptoms to my docs for years but they tell me I'm fine.
I know I'm not alone in this!
Diaezepam has a vasodilator aspect to it and mitochondrial improvements through calming.
I've just started on ginko biloba and ginseng again and the difference is kinda subtle but also strong in its subetly. The fear lessons, I don't feel as much vascular compromise.
Vitamin b complex will help.
I take beta blocks etc too
I've described this to my doctor's as " vascular asthma" for years but they just don't get it.

Personally I think we need crispr to genetically alter our vascular weakness or stem cellsto do the same.
 

Oliver3

Senior Member
Messages
863
Not the sort of research that would suggest a treatment @marcjf but the lead author Klaus Wirth knows lots and lots about drugs, so I expect he has more than a few ideas for a fix.
https://www.healthrising.org/blog/2023/10/18/blood-vessels-long-covid-chronic-fatigue-syndrome/


Cort has a piece on the guy and his ideas.
Cort too recognizes the problems with vascular connective tissue. Anything that doesn't strengthen the vascular system won't address the problem at his root
That said, I'd take anything that ameliorated it
 
Messages
30
My CFS doctor believes microclots are possibly the problem. He has me taking a specific NAC (N-actyl cysteine).
  • Augmented NAC from https://augmentednac.com/en/augmented-nac. I started this a month or so ago.
  • I also take Nattokinase and have for some time.
  • After one week and for several weeks (of the augmented NAC), I felt a noticeable difference. It has since tapered off. However, this is the time of year that I have more fatigue which I believe is due to the numerous viruses in play during the cold and flu season.
  • Therefore, it is still hard to say whether or not this is working.
  • The website spells out the difference between standard NAC and the augmented NAC.
 

Rufous McKinney

Senior Member
Messages
13,389
Augmented NAC
was reading this: so its somehow in much smaller molecules, sounds like.....

Augmented NAC 90 capsules expresses all the beneficial properties of N-Acetylcysteine applied during the production of the capsules. This increases the antioxidant, detoxifying and many other capacities, while reducing the dosage to one third (only 200 mg per capsule), thus also helping people with possible intolerances.

What is Augmented NAC

Thanks to special patented machines using the principles of quantum physics, we have found that it is possible to bring more order to the subatomic structure of the N-acetylcysteine (NAC) molecule, thereby optimising ("augmenting") all the beneficial properties of NAC, in particular the degree of denaturation of the spike protein, which has consistently increased from an average of 12%-15% to 99.8%, as measured in the laboratory.